These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2581786

  • 1. Renal gammagraphy with 99mTc-phosphomycin.
    de Lima JJ, Branco JR, Patricio LC, Rodrigues AJ, Castanheira I.
    Eur J Nucl Med; 1985; 10(3-4):134-7. PubMed ID: 2581786
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-aprotinin: comparison with 99mTc-DMSA in normal and diseased kidneys.
    Aprile C, Saponaro R, Villa G, Lunghi F.
    Nuklearmedizin; 1984 Feb; 23(1):22-6. PubMed ID: 6203101
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A renal imaging agent--99mTc-(Sn)-aprotinin and its preparation and animal experiments].
    Tan TZ, Deng HF.
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Dec; 17(4):299-301. PubMed ID: 2437008
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
    Prvulovich EM, Bomanji JB, Waddington WA, Rudrasingham P, Verbruggen AM, Ell PJ.
    J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with 99mTc-DMSA (dimercaptosuccinic acid), a new renal-imaging agent.
    Handmaker H, Young BW, Lowenstein JM.
    J Nucl Med; 1975 Jan; 16(1):28-32. PubMed ID: 1110402
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liver-spleen visualization by renal imaging agent glucoheptonate.
    Seigman EL, Stover JO, Kelly JA.
    Urology; 1981 Apr; 17(4):384-5. PubMed ID: 7222339
    [Abstract] [Full Text] [Related]

  • 12. Preparation and quality control of 99mTc-calciumgluconate.
    Zmbova B, Djokić D, Jovanović V, Tadzer I, Memedović T.
    Nuklearmedizin; 1983 Jun; 22(3):166-8. PubMed ID: 6622264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Technetium thiodiglycollic acid (99mTc-TDG). A new radiopharmaceutical with the potential for the assessment of renal function.
    Nowotnik DP, Pickett RD, Allen CD.
    Eur J Nucl Med; 1985 Jun; 11(8):285-9. PubMed ID: 4076236
    [Abstract] [Full Text] [Related]

  • 17. [Clinical usefulness of 99mTc-MAG3--a multicenter phase III study].
    Ishii K, Ishibashi A, Torizuka K.
    Kaku Igaku; 1993 May; 30(5):517-28. PubMed ID: 8336411
    [Abstract] [Full Text] [Related]

  • 18. Instant 99mTc-labelled glucoheptonate kit for kidney imaging.
    Agha NH, Al-Hilli M, Karim HM, Al-Hissoni MH, Jassim MN.
    Nuklearmedizin; 1983 Oct; 22(5):246-50. PubMed ID: 6657485
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA.
    Al-Nahhas AA, Jafri RA, Britton KE, Solanki K, Bomanji J, Mather S, Carroll MA, Al-Janabi M, Frusciante V, Ajdinowic B.
    Eur J Nucl Med; 1988 Oct; 14(9-10):453-62. PubMed ID: 2975219
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B, Brandau W, Weber E, Kälble T, Parekh N, Georgi P.
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.